Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Current and Pipeline GLP-1 Agonists Following the 2005 approval of exenatide for Type 2 Diabetes, there have been a series of approvals for GLP-1 agonists in both diabetes and obesity
GLP-1 Medicare Drug Negotiation Price List In January 2025, the Centers for Medicare and Medicaid Services (CMS) announced the inclusion of GLP-1 receptor agonists specifically semaglutide-based medications Ozempic, Wegovy and Rybelsus in the second cycle of the Medicare Drug Price Negotiation Program, as per the Inflation Reduction Act
PlexusDx patients report similar weight loss results (15-22% over 6+ months) at a fraction of the cost, with flexible dosing designed specifically for weight loss goals
And before having surgery or any medical procedures done, ask your healthcare provider if your medication should be temporarily stopped
Always seek advice from a healthcare professional before starting or changing any treatment for side effects
